ACET Q4 2021 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$76M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+1.1% YoY

Gross Profit

$5M100.0% margin

Operating Income

-$16M-284.2% margin

Net Income

-$16M-289.2% margin

EPS (Diluted)

$-7.52

QoQ Revenue Growth

+59.5%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$17M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$339M

Total Liabilities

$36M

Stockholders' Equity

$303M

Cash & Equivalents

$278M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$5M	+1.1%
Gross Profit	$5M	$5M	+1.1%
Operating Income	-$16M	-$9M	-66.2%
Net Income	-$16M	-$9M	-76.5%